Indian drug manufacturers benefit from Big Pharma interest beyond China

China has for nearly 20 years been the preferred location for a range of pharmaceutical research and manufacturing services due to the low cost and speed offered by contract drugmakers there.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yW8GmHF
via IFTTT